Cargando…
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
BACKGROUND: The clinical success of immune checkpoint inhibitors demonstrates that reactivation of the human immune system delivers durable responses for some patients and represents an exciting approach for cancer treatment. An important class of preclinical in vivo models for immuno-oncology is im...
Autores principales: | Zhong, Wenyan, Myers, Jeremy S., Wang, Fang, Wang, Kai, Lucas, Justin, Rosfjord, Edward, Lucas, Judy, Hooper, Andrea T., Yang, Sharon, Lemon, Lu Anna, Guffroy, Magali, May, Chad, Bienkowska, Jadwiga R., Rejto, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941261/ https://www.ncbi.nlm.nih.gov/pubmed/31898484 http://dx.doi.org/10.1186/s12864-019-6344-3 |
Ejemplares similares
-
Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
por: Hooper, Andrea T., et al.
Publicado: (2022) -
GeneTEFlow: A Nextflow-based pipeline for analysing gene and transposable elements expression from RNA-Seq data
por: Liu, Xiaochuan, et al.
Publicado: (2020) -
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus
Publicado: (1984) -
TNER: a novel background error suppression method for mutation detection in circulating tumor DNA
por: Deng, Shibing, et al.
Publicado: (2018) -
PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residues
por: Veeneman, Brendan, et al.
Publicado: (2020)